Laura Tamblyn

2.5k citations
22 papers · 1.6k indexed · h-index 16
Topics
DNA Repair Mechanisms (11 papers)PARP inhibition in cancer therapy (6 papers)Carcinogens and Genotoxicity Assessment (3 papers)
Partner nations
CanadaSingaporeNorway

In The Last Decade

Laura Tamblyn

22 papers receiving 1.6k citations

Peers

Laura Tamblyn
Comparison fields: 5 of 89
  • Molecular Biology 999
  • Oncology 496
  • Immunology 352
  • Cancer Research 250
  • Cell Biology 241
Replace Constanze Wiek with:
Constanze Wiek Germany
Ralph K. Lindemann Germany
Qin Yang China
Moira Sauane United States
Shaozhong Dong China
Daniela S. Daniela Sanchez Bassères Brazil
Emiliano Dalla Italy
Jinguan Lin China
Jianhua Ling United States
Laura Tamblyn relative to Constanze Wiek Germany Constanze Wiek's profile →
Citations per field
00.5×1.5×2.3×
Constanze Wiek · 1×
Citations per year

Countries citing papers authored by Laura Tamblyn

Since Specialization
Citations

This map shows the geographic impact of Laura Tamblyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Tamblyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Tamblyn more than expected).

Fields of papers citing papers by Laura Tamblyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Tamblyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Tamblyn. The network helps show where Laura Tamblyn may publish in the future.

Co-authorship network of co-authors of Laura Tamblyn

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Tamblyn. A scholar is included among the top collaborators of Laura Tamblyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Tamblyn. Laura Tamblyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 204
2 8
3 19
4 46
5 59
6 5
7 121
8 2
9 120
10 11
11 16
12 134
13 28
14 13
15 15
16 69
17 25
18 168
19 54
20 396

About Laura Tamblyn

Laura Tamblyn is a scholar working on Biological Psychiatry, Oncology and Cancer Research, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (11 papers), PARP inhibition in cancer therapy (6 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Oncology (496 citations), Immunology (352 citations) and Cancer Research (250 citations). Laura Tamblyn has collaborated with scholars based in Canada, Singapore and Norway. Frequent co-authors include Anne Hakem, Elzbieta Matysiak‐Zablocki, Razqallah Hakem, Bénédicte Lemmers, Jason Matthews, Eva Migon, Laura MacPherson, Amro Shehabeldin, Leonardo Salmena and J. Peter McPherson. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026